Hybrid Treatment Approach for a Rare Middle Cranial Fossa Intracranial Tumor in a Pediatric Patient: A Case Report
Pediatric central nervous system (CNS) tumors are often classified by distinct histologic and molecular features; however, some tumors remain unclassified, resulting in diagnostic and therapeutic challenges. We report a case of a previously healthy 3-year-old female who presented with right eyelid ptosis and headache. Imaging revealed a right middle cranial fossa mass. Following surgery and histopathologic and molecular analyses, the diagnosis was a malignant neoplasm with mixed neural and myoblastic differentiation, not elsewhere classified based on the current World Health Organization (WHO) classification. We describe a unique hybrid treatment approach for this rare tumor consisting of rhabdomyosarcoma and embryonal treatment regimens.
Authors
- S. Danielle MacNeil (ORCID: https://orcid.org/0000-0001-6666-9055)
- Chantel Cacciotti (ORCID: https://orcid.org/0000-0002-4968-8956)
- Ryan Wang (ORCID: https://orcid.org/0000-0002-8588-7004)
- Glenn Bauman (ORCID: https://orcid.org/0000-0002-5279-7360)
- Shervin Pejhan
- Robert Siddaway (ORCID: https://orcid.org/0000-0003-2013-9467)
- Sandrine de Ribaupierre (ORCID: https://orcid.org/0000-0001-7096-2289)
- Qi Zhang (ORCID: https://orcid.org/0000-0003-4928-2742)
- Cynthia Hawkins
Institutions
- Western University (CA)
- University of Toronto (CA)
- Hospital for Sick Children (CA)
- SickKids Foundation (CA)
- Neurological Surgery (US)
Publication Details
- Journal
- Journal of Pediatric Hematology/Oncology
- Published
- 2025-05-09
- DOI
- https://doi.org/10.1097/mph.0000000000003049
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00